| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $432K | +13.4% | -45.6% |
| SG&A Expense | $893K | +4.9% | +41.5% |
| Operating Income | -$1.4M | -5.4% | +9.2% |
| Pre-tax Income | -$1.6M | -30.2% | +32.2% |
| Net Income | -$1.6M | -30.2% | +32.2% |
| EPS (Basic) | -$2.10 | -22.8% | +78.0% |
| EPS (Diluted) | -$2.10 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $0 | — | -100.0% |
| Current Assets | $1.0M | -43.4% | -78.9% |
| Total Assets | $2.0M | -30.0% | -76.6% |
| Current Liabilities | $800K | +38.8% | -1.7% |
| Total Liabilities | $1.8M | +34.3% | +1.0% |
| Stockholders' Equity | $171K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.6M | — | — |
| Capital Expenditures | $17K | — | — |
| Investing Cash Flow | -$17K | — | — |
| Financing Cash Flow | $1.2M | — | — |
| Free Cash Flow | -$3.6M | — | — |
| -22.8% |
| +78.0% |
| -88.4% |
| -97.4% |